CD4 and prostate carcinoma: Enhanced tumor infiltration of CD3+CD4+, CD3+CD8+ T cells and NK cells were observed in the Myc-dependent prostate cancer (MycCaP) tissues after small molecule inhibitors (MYCi) treatment (27).